# Medlinker

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medlinker

- Industry: Internet
- Headquarters: Chengdu, China
- Website: www.medlinker.com
- Total disclosed funding: $247M
- Latest round: Series D (Jul 31, 2018)
- Investors on record: 10

## About

Founded in 2014 and based in Chengdu, China, Medlinker operates as a doctor social service platform that provides medical solutions. The company has promoted disease management standard operating procedure (SOP) in March 2020. The company has many partners such as China Taiping, Baidu and Tencent Doctorwork.

The company provides medical solutions and platform for doctor and patient. The company's products include Yiliantong, Yilian ME and Yilian APP. The business of the company includes many fields such as diagnosis and treatment services, drug distribution and financial insurance services. Doctor can conduct professional knowledge sharing, case sharing and discussion and clinical communication. The company focuses on mobile medical field. Disease management service includes tumor, cardiovascular, cerebrovascular, diabetes and chronic kidney disease.

## Funding rounds

- Series D, Jul 31, 2018, $146M — Hong Shan, China Renaissance, Zhongtou Zhongcai Capital, Zhongdian Shurong Investment Management
- Series C, Dec 6, 2017, $60M — Hong Shan, Tencent Investment, China Renaissance, China Electronics Corporation, Hermitage Capital Group
- Series B, Aug 1, 2015, $40M — YF Capital, Tencent Investment
- Series A, Feb 1, 2015 — Hong Shan
- Angel, Aug 1, 2014, $0.5M — Ceyuan Ventures, PreAngel Partners

## Investors

- Ceyuan Ventures (https://capitalatlas.ai/funds/ceyuan-ventures) — Angel
- PreAngel Partners — Angel
- Hong Shan — Series A, Series C, Series D
- YF Capital (https://capitalatlas.ai/funds/yf-capital) — Series B
- Tencent Investment — Series B, Series C
- China Renaissance (https://capitalatlas.ai/funds/china-renaissance) — Series C, Series D
- China Electronics Corporation — Series C
- Hermitage Capital Group (https://capitalatlas.ai/funds/hermitage-capital-group) — Series C
- Zhongtou Zhongcai Capital (https://capitalatlas.ai/funds/zhongtou-zhongcai-capital) — Series D
- Zhongdian Shurong Investment Management (https://capitalatlas.ai/funds/zhongdian-shurong-investment-management) — Series D